金城医药：2025年半年度归属于上市公司股东的净利润为43383223.56元

Core Viewpoint - Jincheng Pharmaceutical reported a significant decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [2] Financial Performance - The company achieved a revenue of 1,360,240,655.35 yuan for the first half of 2025, representing a year-on-year decrease of 22.65% [2] - The net profit attributable to shareholders of the listed company was 43,383,223.56 yuan, reflecting a year-on-year decline of 66.78% [2]